96 related articles for article (PubMed ID: 35961028)
41. Narrative review of autoantibodies in idiopathic inflammatory myopathies.
Liu Y; Zheng Y; Hao H; Yuan Y
Ann Transl Med; 2023 Apr; 11(7):291. PubMed ID: 37090051
[TBL] [Abstract][Full Text] [Related]
42. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
Sherman MA; Graf R; Sabbagh SE; Galindo-Feria AS; Pinal-Fernandez I; Pak K; Kishi T; Flegel WA; Targoff IN; Miller FW; Lundberg IE; Rider LG; Mammen AL;
Rheumatology (Oxford); 2023 Feb; 62(SI2):SI226-SI234. PubMed ID: 35961028
[TBL] [Abstract][Full Text] [Related]
43. Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.
Albrecht I; Wick C; Hallgren Å; Tjärnlund A; Nagaraju K; Andrade F; Thompson K; Coley W; Phadke A; Diaz-Gallo LM; Bottai M; Nennesmo I; Chemin K; Herrath J; Johansson K; Wikberg A; Ytterberg AJ; Zubarev RA; Danielsson O; Krystufkova O; Vencovsky J; Landegren N; Wahren-Herlenius M; Padyukov L; Kämpe O; Lundberg IE
J Clin Invest; 2015 Dec; 125(12):4612-24. PubMed ID: 26551678
[TBL] [Abstract][Full Text] [Related]
44. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
[TBL] [Abstract][Full Text] [Related]
45. Autoantibodies Recognizing Specificity Protein 4 Co-occur With Anti-Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis.
Sherman MA; Pak K; Pinal-Fernandez I; Flegel WA; Targoff IN; Miller FW; Rider LG; Mammen AL;
Arthritis Rheumatol; 2023 Sep; 75(9):1668-1677. PubMed ID: 36996276
[TBL] [Abstract][Full Text] [Related]
46. Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis.
Deakin CT; Bowes J; Rider LG; Miller FW; Pachman LM; Sanner H; Rouster-Stevens K; Mamyrova G; Curiel R; Feldman BM; Huber AM; Reed AM; Schmeling H; Cook CG; Marshall LR; Ll Wilkinson MG; Eyre S; Raychaudhuri S; Wedderburn LR;
Hum Mol Genet; 2022 Jul; 31(14):2471-2481. PubMed ID: 35094092
[TBL] [Abstract][Full Text] [Related]
47. Autoantibodies against four-and-a-half-LIM domain 1 (FHL1) in inflammatory myopathies: results from an Australian single-centre cohort.
Galindo-Feria AS; Horuluoglu B; Day J; Fernandes-Cerqueira C; Wigren E; Gräslund S; Proudman S; Lundberg IE; Limaye V
Rheumatology (Oxford); 2022 Oct; 61(10):4145-4154. PubMed ID: 35022656
[TBL] [Abstract][Full Text] [Related]
48. Idiopathic inflammatory myopathies.
Lundberg IE; Fujimoto M; Vencovsky J; Aggarwal R; Holmqvist M; Christopher-Stine L; Mammen AL; Miller FW
Nat Rev Dis Primers; 2021 Dec; 7(1):86. PubMed ID: 34857798
[TBL] [Abstract][Full Text] [Related]
49. Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis.
Pinal-Fernandez I; Pak K; Gil-Vila A; Baucells A; Plotz B; Casal-Dominguez M; Derfoul A; Martinez-Carretero MA; Selva-O'Callaghan A; Sabbagh S; Casciola-Rosen L; Albayda J; Paik J; Tiniakou E; Danoff SK; Lloyd TE; Miller FW; Rider LG; Christopher-Stine L; Mammen AL;
Arthritis Rheumatol; 2022 Feb; 74(2):358-364. PubMed ID: 34313394
[TBL] [Abstract][Full Text] [Related]
50. Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis.
Sabbagh SE; Pinal-Fernandez I; Casal-Dominguez M; Albayda J; Paik JJ; Miller FW; Rider LG; Mammen AL; Christopher-Stine L;
Clin Rheumatol; 2021 Oct; 40(10):4095-4100. PubMed ID: 33851273
[TBL] [Abstract][Full Text] [Related]
51. The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity.
Tansley SL; Li D; Betteridge ZE; McHugh NJ
Rheumatology (Oxford); 2020 Aug; 59(8):2109-2114. PubMed ID: 32030410
[TBL] [Abstract][Full Text] [Related]
52. Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups.
Rothwell S; Chinoy H; Lamb JA; Miller FW; Rider LG; Wedderburn LR; McHugh NJ; Mammen AL; Betteridge ZE; Tansley SL; Bowes J; Vencovský J; Deakin CT; Dankó K; Vidya L; Selva-O'Callaghan A; Pachman LM; Reed AM; Molberg Ø; Benveniste O; Mathiesen PR; Radstake TRDJ; Doria A; de Bleecker J; Lee AT; Hanna MG; Machado PM; Ollier WE; Gregersen PK; Padyukov L; O'Hanlon TP; Cooper RG; Lundberg IE;
Ann Rheum Dis; 2019 Jul; 78(7):996-1002. PubMed ID: 31138531
[TBL] [Abstract][Full Text] [Related]
53. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
Sabbagh S; Pinal-Fernandez I; Kishi T; Targoff IN; Miller FW; Rider LG; Mammen AL;
Ann Rheum Dis; 2019 Jul; 78(7):988-995. PubMed ID: 31018961
[TBL] [Abstract][Full Text] [Related]
54. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
[TBL] [Abstract][Full Text] [Related]
55. Medications received by patients with juvenile dermatomyositis.
Kishi T; Bayat N; Ward MM; Huber AM; Wu L; Mamyrova G; Targoff IN; Warren-Hicks WJ; Miller FW; Rider LG;
Semin Arthritis Rheum; 2018 Dec; 48(3):513-522. PubMed ID: 29773230
[TBL] [Abstract][Full Text] [Related]
56. The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis.
Schiffenbauer A; Faghihi-Kashani S; O'Hanlon TP; Flegel WA; Adams SD; Targoff IN; Oddis CV; Ytterberg SR; Aggarwal R; Christopher-Stine L; Shamim EA; Dellaripa PF; Danoff SK; Mammen AL; Miller FW
Semin Arthritis Rheum; 2018 Dec; 48(3):504-512. PubMed ID: 29703532
[TBL] [Abstract][Full Text] [Related]
57. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
Yeker RM; Pinal-Fernandez I; Kishi T; Pak K; Targoff IN; Miller FW; Rider LG; Mammen AL;
Ann Rheum Dis; 2018 May; 77(5):714-719. PubMed ID: 29363513
[TBL] [Abstract][Full Text] [Related]
58. Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
Kishi T; Rider LG; Pak K; Barillas-Arias L; Henrickson M; McCarthy PL; Shaham B; Weiss PF; Horkayne-Szakaly I; Targoff IN; Miller FW; Mammen AL;
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1088-1094. PubMed ID: 28129483
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
